InvestorsHub Logo
Followers 7
Posts 565
Boards Moderated 0
Alias Born 03/17/2011

Re: gi197845 post# 3143

Wednesday, 07/13/2022 1:38:45 PM

Wednesday, July 13, 2022 1:38:45 PM

Post# of 3191
- If you really need to go all the way back to June 21st, here's another analyst on that same day.

ACADIA Pharmaceuticals (ACAD) Gets a Buy Rating from JMP Securities
June 21 2022 - 08:26AM

In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report), with a price target of $23.00. The company's shares closed last Thursday at $19.51.

Currently, the analyst consensus on ACADIA Pharmaceuticals is a Moderate Buy with an average price target of $27.17, a 39.4% upside from current levels.
Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACAD News